[Prospects of the use of cyclosporin A in rheumatic diseases].
E L
EL
Nasonov
V Z
VZ
Shtutman
V A
VA
Nasonova
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000276:immunology; D001528:Behcet Syndrome / Q000188:drug therapy / Q000276:immunology; D002986:Clinical Trials as Topic; D018849:Controlled Clinical Trials as Topic; D016572:Cyclosporine / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy / Q000276:immunology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology; D051379:Mice; D008814:Mice, Inbred NZB; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000276:immunology; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000276:immunology
D005938:Glucocorticoids; D016572:Cyclosporine
Perspektivy primeneniia tsiklosporina A pri revmaticheskikh zabolevaniiakh.